Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology

Keyphrases

• Cardiology 100%
• β-Adrenergic Blocking Agent 100%
• Pharmacokinetic Variability 100%
• Area under the Concentration Curve 75%
• Steady State 50%
• Pharmacokinetic Study 50%
• Coefficient of Variation 50%
• Metoprolol 50%
• Cmax 50%
• Pharmacogenetics 25%
• Atenolol 25%
• Adverse Events 25%
• Treatment Effect 25%
• Medical Treatment 25%
• Plasma Concentration 25%
• PubMed 25%
• Pharmacokinetics 25%
• Sotalol 25%
• Patient Characteristics 25%
• Low-to-moderate 25%
• Carvedilol 25%
• Propranolol 25%
• High Variability 25%
• Pindolol 25%
• Labetalol 25%
• Bisoprolol 25%
• Nebivolol 25%
• Personalized Approach 25%
• Steady-state Studies 25%
• Nadolol 25%
• Dynamic Characteristics 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Beta Adrenergic Receptor Blocking Agent 100%
• Pharmacokinetics 100%
• Metoprolol 28%
• Atenolol 14%
• Pharmacogenetics 14%
• Adverse Event 14%
• Combination Therapy 14%
• Sotalol 14%
• Carvedilol 14%
• Propranolol 14%
• Pindolol 14%
• Labetalol 14%
• Bisoprolol 14%
• Nebivolol 14%
• Nadolol 14%